Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Nadia Giarratana"'
Autor:
Donatella Panatto, Andrea Orsi, Bianca Bruzzone, Valentina Ricucci, Guido Fedele, Giorgio Reiner, Nadia Giarratana, Alexander Domnich, Giancarlo Icardi, STX Study Group
Publikováno v:
Viruses, Vol 14, Iss 5, p 1033 (2022)
Sentinox (STX) is an acid-oxidizing solution containing hypochlorous acid in spray whose virucidal activity against SARS-CoV-2 has been demonstrated. In this paper, results of a randomized controlled trial (RCT) on the efficacy of STX in reducing vir
Externí odkaz:
https://doaj.org/article/d1b01dd0cc844c76aa20541ebf44e34e
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 4, p 2227 (2022)
Phenylketonuria (PKU) is a rare autosomal recessive inborn error of metabolism where the mainstay of treatment is a Phe restricted diet consisting of a combination of limited amounts of natural protein with supplementation of Phe-free or low-Phe prot
Externí odkaz:
https://doaj.org/article/3a1cf3fba38d4b60b74321c709e8318e
Autor:
Nadia Giarratana PhD, Guglielmo Gallina PhD, Valentina Panzeri PharmD, Alessandra Frangi MBiol, Andrea Canobbio PhD, Giorgio Reiner PharmD
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 6 (2018)
An innovative technology (Physiomimic Technology) has been applied to amino acids (AAs) formulated for patients with phenylketonuria, with the objective of masking AA taste and odor and prolonging AA release in the gut, allowing a physiological absor
Externí odkaz:
https://doaj.org/article/5b2f68edb20847faac229194b80859b3
Publikováno v:
Molecular Genetics and Metabolism. 138:107406
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0a206619d5dafd2d530b8707a5656e8
https://doi.org/10.1016/j.ymgme.2023.107406
https://doi.org/10.1016/j.ymgme.2023.107406
Publikováno v:
European Archives of Oto-Rhino-Laryngology
Introduction To eliminate the COVID-19 pandemic, the transmission of the virus SARS-CoV-2 among the population needs to be blocked and/or at least reduced. Upper respiratory tract viral loads are highest in the early stages of the disease, and high l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b76422082b95e95083d82f3affa4c6
https://pubmed.ncbi.nlm.nih.gov/33575830
https://pubmed.ncbi.nlm.nih.gov/33575830
Autor:
Giorgio Reiner, Guglielmo Gallina, Valentina Panzeri, Andrea Canobbio, Nadia Giarratana, Alessandra Frangi
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 6 (2018)
Journal of Inborn Errors of Metabolism and Screening v.6 2018
Journal of Inborn Errors of Metabolism and Screening
Instituto Genética para Todos (IGPT)
instacron:IGPT
Journal of Inborn Errors of Metabolism and Screening, Volume: 6, Article number: e170030, Published: 28 FEB 2019
Journal of Inborn Errors of Metabolism and Screening v.6 2018
Journal of Inborn Errors of Metabolism and Screening
Instituto Genética para Todos (IGPT)
instacron:IGPT
Journal of Inborn Errors of Metabolism and Screening, Volume: 6, Article number: e170030, Published: 28 FEB 2019
An innovative technology (Physiomimic Technology) has been applied to amino acids (AAs) formulated for patients with phenylketonuria, with the objective of masking AA taste and odor and prolonging AA release in the gut, allowing a physiological absor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db92b028659946ff8bb8b46b9ca60148
https://doaj.org/article/5b2f68edb20847faac229194b80859b3
https://doaj.org/article/5b2f68edb20847faac229194b80859b3
Publikováno v:
International Journal of Pharmaceutics. 393:55-60
The aim of the research was to assess the bioequivalence between Rapidfilm, a new patented delivery system, versus the traditional orodispersible tablet (ODT). A randomized, two-way, single dose, crossover, bioequivalence study was conducted in 24 fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::771320b4cce85975aa7dd009f7d68a39
https://doi.org/10.1016/j.ijpharm.2010.03.055
https://doi.org/10.1016/j.ijpharm.2010.03.055
Autor:
Giuseppe Penna, Susana Amuchastegui, Marisa Vulcano, Kenn C. Daniel, Silvano Sozzani, Luciano Adorini, Nadia Giarratana
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
1,25-Dihydroxy vitamin D3 (1,25(OH)2D3) is an immunomodulatory agent inducing dendritic cells (DCs) to become tolerogenic. To further understand its mechanisms of action, we have examined the effects of 1,25(OH)2D3 on tolerogenic properties of blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210011aed6e3cc251ce72dc38297f5ed
https://doi.org/10.4049/jimmunol.178.1.145
https://doi.org/10.4049/jimmunol.178.1.145
Autor:
Nadia Giarratana, Davide Melandri, Paolo Lualdi, Armando De Angelis, Roberto Orioli, Giovanni Ponzielli, Valentina Reiner
Publikováno v:
Burns. 32:964-972
A multi-centre, open, within-patient controlled study was performed on 23 adult burnt patients to investigate the effectiveness, safety and tolerability of Veloderm in comparison with Algisite M and Jaloskin in split-thickness skin graft donor site c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5865c1110a75c0b6b1818d6995f831fa
https://doi.org/10.1016/j.burns.2006.03.013
https://doi.org/10.1016/j.burns.2006.03.013
Publikováno v:
Current Medicinal Chemistry Anti-Inflammatory & Anti-Allergy Agents. 4:645-651
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8e9c9ab6bd63937035032c07d65667d
https://doi.org/10.2174/156801405774933197
https://doi.org/10.2174/156801405774933197